Lactobacillus sakei proBio65 and Reduced Psoriasis Inflammation

• The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity.

  • 2023-11-13
  • Review
  • Inflammation 47(1)
  • • Eva Reali
    • Cristiana Caliceti
    • Antonello Lorenzini
    • Paola Rizzo

  • PubMed: 37953417
  • DOI: 10.1007/s10753-023-01915-1

  1 Insight on

  • Reduced Psoriasis Inflammation

  • Low evidence

  "the possibility of merging systemic treatment and tailored microbial modifying therapies could increase the efficacy of the current treatments" and microbiota-modulating strategies may help "prevent psoriasis exacerbation" and modulate inflammation involved in psoriatic disease

  Effect

  Beneficial

  Effect size

  Small